Overview

Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects

Status:
Completed
Trial end date:
2019-01-31
Target enrollment:
0
Participant gender:
All
Summary
Treatment with colloidal solutions has during long time been a cornerstone within intensive care. Lately, doubts have been raised about synthetic colloids, and the natural albumin has been used more and more. One of these solutions is the hyperoncotic "Albumin 20%". However there are still many aspects of the physiological effects of hyperoncotic albumin, that are not known. In this study physiological effects will be studied in burn patients and healthy subjects. The colloid osmotic pressure and the increase of the plasma volume will be measured in 15 healthy subjects and in 15 burn patients. The effect on the plasma volume will be studied using hemoglobin as a marker of dilution. Colloids osmotic pressure and albumin concentration will be measured directly and urin production will also be measured. Blood samples will be collected during 4 to 5 hours to achieve a profile over the changes.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University Hospital, Linkoeping
Criteria
Inclusion Criteria:

- For healthy individuals: Healthy, without allergies and with the age of 18 years or
above.

- For patients: Burn injury exceeding 6-8 Total Burned Surface Area %

Exclusion Criteria:

- Heart failure

- Signs of kidney injury/failure

- Severe allergies